Pharmaceutical Logistics Market Size, Trends and Insights By Component (Storage, Transportation, Monitoring Components), By Operation (Seaways, Roadways, Railways, Airways), By Application (Bio Pharma, Chemical Pharma, Speciality Pharma), and By Region - Global Industry Overview, Statistical Data, Competitive Analysis, Share, Outlook, and Forecast 2024–2033
Report Snapshot
| Study Period: | 2024-2033 |
| Fastest Growing Market: | Asia-Pacific |
| Largest Market: | Europe |
Major Players
- FedEx
- United Parcel Service of America Inc.
- Abiomed
- BioVentrix
- R. Bard
- Others
Reports Description
Global Pharmaceutical Logistics Market was valued at USD 68.5 Billion in 2023 and is expected to reach USD 125.5 Billion by 2032, at a CAGR of 5.5% during the forecast period 2023 – 2032.
Pharmaceutical logistics is the specialist management of a supply chain and shipment operations that is adapted to the specific needs of pharmaceutical products. It entails planning, implementing, and controlling the flow of pharmaceutical commodities from production facilities or suppliers to the destination of usage.
Pharmaceutical Logistics Market: Growth Factors
Increasing demand for cold chain logistics
The expanding need for temperature-controlled shipping and storage of pharmaceutical items is the primary driver of growth in the pharmaceutical logistics industry. Many drugs, vaccines, and biologics require precise temperature regulation to be effective and safe.
As global healthcare infrastructure expands, demand for temperature-sensitive medications is fast increasing, particularly in emerging nations where access to healthcare is expanding. As a result, pharmaceutical businesses are increasingly reliant on cold chain logistics suppliers to maintain product integrity along the supply chain.
This tendency is pushing investments in cold storage facilities, refrigerated transportation, and temperature monitoring systems, so propelling the pharmaceutical logistics market forward.
For instance, Sonoco ThermoSafe launched the Pegasus unit-load device (ULD), and around a dozen air carriers and logistics companies have validated its usage in worldwide air freight. The ULD is unique for being a passive (non-powered) unit certified for 300 hours of service in temperatures ranging from 2 to 8°C, while also being FAA and EASA-approved as a flying equipment component.
Cryoport, which specializes in ultracold biologics shipment, often using liquid nitrogen at -170°C, is launching its Elite branded ultracold container, which is rated for -80°C and uses dry ice.
Rising need for pharmaceutical products due to increase in medication
The pharmaceutical logistics industry is seeing substantial expansion due to rising demand for pharmaceutical goods, which is being driven by trends such as aging populations, the incidence of chronic illnesses, and advances in medical treatment.
This increase in demand demands a strong and efficient supply chain infrastructure to enable the timely and secure delivery of drugs to end consumers globally.
Pharmaceutical logistics companies are spending more on temperature-controlled storage facilities, innovative tracking systems, and tight quality control techniques to accommodate expanding demand while preserving the integrity of products and regulatory compliance.
As a result, the growing demand for pharmaceutical goods is transforming and extending the pharmaceutical logistics market, spurring innovation and adaptation to meet the changing needs of the healthcare industry.
For instance, in Organization for Economic Cooperation and Development (OECD) nations, the consumption of cholesterol-lowering medications has almost tripled, the use of antidepressants has doubled, and the consumption of antihypertensive and antidiabetic pharmaceuticals has nearly doubled.
As economies flourished and medical supply and insurance systems expanded, so did the demand for both domestic and foreign pharmaceuticals. In addition, was demand expanding, but the diversity of pharmaceutical demands, as emerging markets addressed noncommunicable illnesses a prominent player in larger economies, such as diabetes and hypertension. The expanding global population is also fuelling more medication usage.
Pharmaceutical Logistics Market: Restraints
High operational cost of cold chain logistics
Sustaining the essential temperature-controlled settings throughout the whole supply chain, from manufacture to delivery, requires significant investment in specialized storage facilities, cooling systems, and transportation methods.
These expenditures are increased by the necessity for ongoing monitoring and validation to assure regulatory compliance. Furthermore, the severe temperature requirements for certain pharmaceutical items add complexity and risk to logistics operations, resulting in increased insurance premiums and investments in backup systems to reduce possible losses due to temperature fluctuations.
Moreover, the necessity for timely and dependable delivery of temperature-sensitive drugs may entail the use of premium transportation services, increasing operating expenses.
Pharmaceutical Logistics Market: Opportunities
Progressively R&D efforts by pharmaceutical companies to develop new drug
Pharmaceutical business’s extensive research and development (R&D) efforts to generate new medication entities have a significant impact on the pharmaceutical logistics sector.
As pharmaceutical firms invest substantially in researching and developing breakthrough pharmaceuticals to meet a wide range of medical requirements, the demand for efficient logistical solutions to support their distribution grows.
The pharmaceutical logistics sector reacts by offering customized services designed to meet the particular needs of carrying and storing these sensitive and frequently high-value pharmaceutical items.
This includes the use of sophisticated temperature-controlled systems, tight quality control methods, and adherence to regulatory requirements to maintain the pharmaceuticals’ integrity and safety along the supply chain.
Finally, development and innovation in pharmaceutical R&D stimulate the expansion and sophistication of the pharmaceutical industry. According to the Food and Drug Administration’s recent surveys, the typical R&D expenditure for a new medicine ranges between less than $1 billion to more than $2 billion. These figures cover the expenditures of both laboratory research and clinical trials for successful new medications.
Pharmaceutical Logistics Market: Segmentation Analysis
The global Pharmaceutical Logistics market is segmented by component, operations, application and region. Based on components, the market is classified into storage, transportation, and monitoring components. Storage dominated the market in 2022 with a market share of 45% and is expected to keep its dominance during the forecast period 2024-2032.
Proper storage facilities are critical to preserving the integrity and efficacy of these delicate commodities. Vaccines, biologics, and other temperature-sensitive pharmaceuticals require specialized temperature-controlled storage, which is also known as cold chain logistics.
Pharmaceuticals must be maintained at particular temperatures throughout the supply chain to avoid deterioration and maintain product quality. This requires investment in cutting-edge storage infrastructure and technology, such as refrigerated warehouses and temperature-monitoring systems.
Additionally, severe regulatory criteria need optimal storage conditions to fulfill safety and effectiveness requirements. As a result, the demand for sophisticated storage solutions fuels expansion in the pharmaceutical logistics industry.
Based on operation, the market is classified into seaways, roadways, railways, and airways. The medical diagnostics segment dominated the market in 2022 with a market share of 40% and is expected to keep its dominance during the forecast period 2024-2032.
Airways play an important part in pushing the pharmaceutical logistics industry because of their capacity to carry pharmaceutical items across great distances in a timely and dependable manner. With the pharmaceutical sector becoming more globalized and the requirement for medications to be delivered on time, air transport offers a quick and effective alternative.
Airways provide sophisticated cargo handling facilities and temperature-controlled settings required for shipping sensitive pharmaceutical items, preserving their integrity and efficacy throughout the voyage. Furthermore, air transport allows pharmaceutical corporations to swiftly reach remote markets, making it easier to distribute life-saving pharmaceuticals and vaccinations throughout the world.
Based on application, the market is classified into biopharma, chemical pharma and speciality pharma. The Biopharma segment dominated the market in 2022 with a market share of 45% and is expected to keep its dominance during the forecast period 2024-2032.
Biopharmaceutical businesses play an important role in fostering innovation and complexity in the pharmaceutical logistics industry. Furthermore, biopharma businesses regularly participate in worldwide clinical trials, necessitating the flawless coordination of supply chains across several countries.
As a result, they push the frontiers of pharmaceutical logistics, leading to the development of cutting-edge technology like real-time temperature monitoring, GPS tracking, and data analytics. Furthermore, the increasing need for precision medicine and tailored medicines emphasizes the importance of nimble and efficient logistics systems.
Report Scope
| Feature of the Report | Details |
| Market Size in 2023 | USD 68.5 Billion |
| Projected Market Size in 2032 | USD 125.5 Billion |
| Market Size in 2022 | USD 67.9 Billion |
| CAGR Growth Rate | 5.5% CAGR |
| Base Year | 2023 |
| Forecast Period | 2024-2033 |
| Key Segment | By Component, Operation, Application and Region |
| Report Coverage | Revenue Estimation and Forecast, Company Profile, Competitive Landscape, Growth Factors and Recent Trends |
| Regional Scope | North America, Europe, Asia Pacific, Middle East & Africa, and South & Central America |
| Buying Options | Request tailored purchasing options to fulfil your requirements for research. |
Pharmaceutical Logistics Market: Regional Analysis
By region, Pharmaceutical Logistics market is segmented into North America, Europe, Asia-Pacific, Latin America, Middle East & Africa. Europe dominated the global Pharmaceutical Logistics market in 2022 with a market share of 40% in 2022 and is expected to keep its dominance during the forecast period 2024-2032.
Europe leads the pharmaceutical logistics industry through a variety of sources. Its strong regulatory framework maintains high standards for pharmaceutical storage, transportation, and distribution, creating a demand for specialist logistics solutions.
To address the various and rigorous needs of the continent’s wide network of biopharmaceutical manufacturers, suppliers, and healthcare providers, efficient supply chain management is required.
Furthermore, Europe’s concentration on pharmaceutical R&D promotes innovation in logistical technology and processes. In addition, the rising need for temperature-controlled transportation solutions, notably for biologics and vaccines, drives expenditure on cold chain logistics infrastructure.
Furthermore, Europe’s commitment to sustainability supports the use of environmentally friendly logistical strategies like as green packaging and effective route planning, which helps shape the healthcare logistics ecosystem.
Overall, Europe’s regulatory environment, industry experience, culture of innovation, and focus on sustainability all contribute to the growth and evolution of the region’s pharmaceutical logistics business.
Pharmaceutical Logistics Market: Recent Developments
- In February 2022, GEODIS, a global leader in transportation and logistics, announced that it had reached a contractual deal to buy Keppel Logistics. The endeavour will dramatically expand GEODIS’ contract logistics presence and eCommerce fulfilment services in Singapore and Southeast Asia.
- In January 2024, Air Canada Cargo has joined the Pharma. Aero. Through this collaboration between industries platform to expand its pharmaceuticals freight handling expertise.
- In December 2023, World Courier announced that it would open three more stations across North America to meet rising pharmaceutical loads. The Cencora-owned firm will open additional locations in Denver, Indianapolis, and San Diego to increase its ability to store, handle, and deliver pharmaceutical items, particularly those requiring cryogenic storage.
List of the prominent players in the Pharmaceutical Logistics Market:
- FedEx
- United Parcel Service of America Inc.
- Abiomed
- BioVentrix
- R. Bard
- LifeConEx
- Abbott Vascular
- Abiomed
- AtriCure
- UPS
- Air Canada
- VersaCold Logistics Services
- World Courier
- Biotronik
- Deutsche Post DHL
- DB Schenker
- CEVA Logistics
- Agility
- SF Express
- Biosensors International
- Others
These key players are adopting various growth strategies such as mergers & acquisitions, joint ventures, expansion, strategic alliances, new product launches, etc. to enhance their business operations and revenues.
The Pharmaceutical Logistics Market is segmented as follows:
By Component
- Storage
- Transportation
- Monitoring Components
By Operation
- Seaways
- Roadways
- Railways
- Airways
By Application
- Bio Pharma
- Chemical Pharma
- Speciality Pharma
Regional Coverage:
North America
- U.S.
- Canada
- Mexico
- Rest of North America
Europe
- Germany
- France
- U.K.
- Russia
- Italy
- Spain
- Netherlands
- Rest of Europe
Asia Pacific
- China
- Japan
- India
- New Zealand
- Australia
- South Korea
- Taiwan
- Rest of Asia Pacific
The Middle East & Africa
- Saudi Arabia
- UAE
- Egypt
- Kuwait
- South Africa
- Rest of the Middle East & Africa
Latin America
- Brazil
- Argentina
- Rest of Latin America
Table of Contents
- Chapter 1. Preface
- 1.1 Report Description and Scope
- 1.2 Research scope
- 1.3 Research methodology
- 1.3.1 Market Research Type
- 1.3.2 Market Research Methodology
- Chapter 2. Executive Summary
- 2.1 Global Pharmaceutical Logistics Market, (2024 – 2033) (USD Billion)
- 2.2 Global Pharmaceutical Logistics Market: snapshot
- Chapter 3. Global Pharmaceutical Logistics Market – Industry Analysis
- 3.1 Pharmaceutical Logistics Market: Market Dynamics
- 3.2 Market Drivers
- 3.2.1 Increasing demand for cold chain logistics
- 3.2.2 Rising need for pharmaceutical products due to increase in medication
- 3.3 Market Restraints
- 3.4 Market Opportunities
- 3.5 Market Challenges
- 3.6 Porter’s Five Forces Analysis
- 3.7 Market Attractiveness Analysis
- 3.7.1 Market Attractiveness Analysis By Component
- 3.7.2 Market Attractiveness Analysis By Operation
- 3.7.3 Market Attractiveness Analysis By Application
- Chapter 4. Global Pharmaceutical Logistics Market- Competitive Landscape
- 4.1 Company market share analysis
- 4.1.1 Global Pharmaceutical Logistics Market: Company Market Share, 2022
- 4.2 Strategic development
- 4.2.1 Acquisitions & mergers
- 4.2.2 New Product launches
- 4.2.3 Agreements, partnerships, collaboration, and joint ventures
- 4.2.4 Research and development and Regional expansion
- 4.3 Price trend analysis
- 4.1 Company market share analysis
- Chapter 5. Global Pharmaceutical Logistics Market – Component Analysis
- 5.1 Global Pharmaceutical Logistics Market Overview: By Component
- 5.1.1 Global Pharmaceutical Logistics Market Share, By Component, 2022 and – 2033
- 5.2 Storage
- 5.2.1 Global Pharmaceutical Logistics Market by Storage, 2024 – 2033 (USD Billion)
- 5.3 Transportation
- 5.3.1 Global Pharmaceutical Logistics Market by Transportation, 2024 – 2033 (USD Billion)
- 5.4 Monitoring Components
- 5.4.1 Global Pharmaceutical Logistics Market by Monitoring Components, 2024 – 2033 (USD Billion)
- 5.1 Global Pharmaceutical Logistics Market Overview: By Component
- Chapter 6. Global Pharmaceutical Logistics Market – Operation Analysis
- 6.1 Global Pharmaceutical Logistics Market Overview: By Operation
- 6.1.1 Global Pharmaceutical Logistics Market Share, By Operation, 2022 and – 2033
- 6.2 Seaways
- 6.2.1 Global Pharmaceutical Logistics Market by Seaways, 2024 – 2033 (USD Billion)
- 6.3 Roadways
- 6.3.1 Global Pharmaceutical Logistics Market by Roadways, 2024 – 2033 (USD Billion)
- 6.4 Railways
- 6.4.1 Global Pharmaceutical Logistics Market by Railways, 2024 – 2033 (USD Billion)
- 6.5 Airways
- 6.5.1 Global Pharmaceutical Logistics Market by Airways, 2024 – 2033 (USD Billion)
- 6.1 Global Pharmaceutical Logistics Market Overview: By Operation
- Chapter 7. Global Pharmaceutical Logistics Market – Application Analysis
- 7.1 Global Pharmaceutical Logistics Market Overview: By Application
- 7.1.1 Global Pharmaceutical Logistics Market Share, By Application, 2022 and – 2033
- 7.2 Bio Pharma
- 7.2.1 Global Pharmaceutical Logistics Market by Bio Pharma, 2024 – 2033 (USD Billion)
- 7.3 Chemical Pharma
- 7.3.1 Global Pharmaceutical Logistics Market by Chemical Pharma, 2024 – 2033 (USD Billion)
- 7.4 Speciality Pharma
- 7.4.1 Global Pharmaceutical Logistics Market by Speciality Pharma, 2024 – 2033 (USD Billion)
- 7.1 Global Pharmaceutical Logistics Market Overview: By Application
- Chapter 8. Pharmaceutical Logistics Market – Regional Analysis
- 8.1 Global Pharmaceutical Logistics Market Regional Overview
- 8.2 Global Pharmaceutical Logistics Market Share, by Region, 2022 & – 2033 (USD Billion)
- 8.3. North America
- 8.3.1 North America Pharmaceutical Logistics Market, 2024 – 2033 (USD Billion)
- 8.3.1.1 North America Pharmaceutical Logistics Market, by Country, 2024 – 2033 (USD Billion)
- 8.3.1 North America Pharmaceutical Logistics Market, 2024 – 2033 (USD Billion)
- 8.4 North America Pharmaceutical Logistics Market, by Component, 2024 – 2033
- 8.4.1 North America Pharmaceutical Logistics Market, by Component, 2024 – 2033 (USD Billion)
- 8.5 North America Pharmaceutical Logistics Market, by Operation, 2024 – 2033
- 8.5.1 North America Pharmaceutical Logistics Market, by Operation, 2024 – 2033 (USD Billion)
- 8.6 North America Pharmaceutical Logistics Market, by Application, 2024 – 2033
- 8.6.1 North America Pharmaceutical Logistics Market, by Application, 2024 – 2033 (USD Billion)
- 8.7. Europe
- 8.7.1 Europe Pharmaceutical Logistics Market, 2024 – 2033 (USD Billion)
- 8.7.1.1 Europe Pharmaceutical Logistics Market, by Country, 2024 – 2033 (USD Billion)
- 8.7.1 Europe Pharmaceutical Logistics Market, 2024 – 2033 (USD Billion)
- 8.8 Europe Pharmaceutical Logistics Market, by Component, 2024 – 2033
- 8.8.1 Europe Pharmaceutical Logistics Market, by Component, 2024 – 2033 (USD Billion)
- 8.9 Europe Pharmaceutical Logistics Market, by Operation, 2024 – 2033
- 8.9.1 Europe Pharmaceutical Logistics Market, by Operation, 2024 – 2033 (USD Billion)
- 8.10 Europe Pharmaceutical Logistics Market, by Application, 2024 – 2033
- 8.10.1 Europe Pharmaceutical Logistics Market, by Application, 2024 – 2033 (USD Billion)
- 8.11. Asia Pacific
- 8.11.1 Asia Pacific Pharmaceutical Logistics Market, 2024 – 2033 (USD Billion)
- 8.11.1.1 Asia Pacific Pharmaceutical Logistics Market, by Country, 2024 – 2033 (USD Billion)
- 8.11.1 Asia Pacific Pharmaceutical Logistics Market, 2024 – 2033 (USD Billion)
- 8.12 Asia Pacific Pharmaceutical Logistics Market, by Component, 2024 – 2033
- 8.12.1 Asia Pacific Pharmaceutical Logistics Market, by Component, 2024 – 2033 (USD Billion)
- 8.13 Asia Pacific Pharmaceutical Logistics Market, by Operation, 2024 – 2033
- 8.13.1 Asia Pacific Pharmaceutical Logistics Market, by Operation, 2024 – 2033 (USD Billion)
- 8.14 Asia Pacific Pharmaceutical Logistics Market, by Application, 2024 – 2033
- 8.14.1 Asia Pacific Pharmaceutical Logistics Market, by Application, 2024 – 2033 (USD Billion)
- 8.15. Latin America
- 8.15.1 Latin America Pharmaceutical Logistics Market, 2024 – 2033 (USD Billion)
- 8.15.1.1 Latin America Pharmaceutical Logistics Market, by Country, 2024 – 2033 (USD Billion)
- 8.15.1 Latin America Pharmaceutical Logistics Market, 2024 – 2033 (USD Billion)
- 8.16 Latin America Pharmaceutical Logistics Market, by Component, 2024 – 2033
- 8.16.1 Latin America Pharmaceutical Logistics Market, by Component, 2024 – 2033 (USD Billion)
- 8.17 Latin America Pharmaceutical Logistics Market, by Operation, 2024 – 2033
- 8.17.1 Latin America Pharmaceutical Logistics Market, by Operation, 2024 – 2033 (USD Billion)
- 8.18 Latin America Pharmaceutical Logistics Market, by Application, 2024 – 2033
- 8.18.1 Latin America Pharmaceutical Logistics Market, by Application, 2024 – 2033 (USD Billion)
- 8.19. The Middle-East and Africa
- 8.19.1 The Middle-East and Africa Pharmaceutical Logistics Market, 2024 – 2033 (USD Billion)
- 8.19.1.1 The Middle-East and Africa Pharmaceutical Logistics Market, by Country, 2024 – 2033 (USD Billion)
- 8.19.1 The Middle-East and Africa Pharmaceutical Logistics Market, 2024 – 2033 (USD Billion)
- 8.20 The Middle-East and Africa Pharmaceutical Logistics Market, by Component, 2024 – 2033
- 8.20.1 The Middle-East and Africa Pharmaceutical Logistics Market, by Component, 2024 – 2033 (USD Billion)
- 8.21 The Middle-East and Africa Pharmaceutical Logistics Market, by Operation, 2024 – 2033
- 8.21.1 The Middle-East and Africa Pharmaceutical Logistics Market, by Operation, 2024 – 2033 (USD Billion)
- 8.22 The Middle-East and Africa Pharmaceutical Logistics Market, by Application, 2024 – 2033
- 8.22.1 The Middle-East and Africa Pharmaceutical Logistics Market, by Application, 2024 – 2033 (USD Billion)
- Chapter 9. Company Profiles
- 9.1 FedEx
- 9.1.1 Overview
- 9.1.2 Financials
- 9.1.3 Product Portfolio
- 9.1.4 Business Strategy
- 9.1.5 Recent Developments
- 9.2 United Parcel Service of America Inc.
- 9.2.1 Overview
- 9.2.2 Financials
- 9.2.3 Product Portfolio
- 9.2.4 Business Strategy
- 9.2.5 Recent Developments
- 9.3 Abiomed
- 9.3.1 Overview
- 9.3.2 Financials
- 9.3.3 Product Portfolio
- 9.3.4 Business Strategy
- 9.3.5 Recent Developments
- 9.4 BioVentrix
- 9.4.1 Overview
- 9.4.2 Financials
- 9.4.3 Product Portfolio
- 9.4.4 Business Strategy
- 9.4.5 Recent Developments
- 9.5 C. R. Bard
- 9.5.1 Overview
- 9.5.2 Financials
- 9.5.3 Product Portfolio
- 9.5.4 Business Strategy
- 9.5.5 Recent Developments
- 9.6 LifeConEx
- 9.6.1 Overview
- 9.6.2 Financials
- 9.6.3 Product Portfolio
- 9.6.4 Business Strategy
- 9.6.5 Recent Developments
- 9.7 Abbott Vascular
- 9.7.1 Overview
- 9.7.2 Financials
- 9.7.3 Product Portfolio
- 9.7.4 Business Strategy
- 9.7.5 Recent Developments
- 9.9 AtriCure
- 9.9.1 Overview
- 9.9.2 Financials
- 9.9.3 Product Portfolio
- 9.9.4 Business Strategy
- 9.9.5 Recent Developments
- 9.10 UPS
- 9.10.1 Overview
- 9.10.2 Financials
- 9.10.3 Product Portfolio
- 9.10.4 Business Strategy
- 9.10.5 Recent Developments
- 9.11 Air Canada
- 9.11.1 Overview
- 9.11.2 Financials
- 9.11.3 Product Portfolio
- 9.11.4 Business Strategy
- 9.11.5 Recent Developments
- 9.12 VersaCold Logistics Services
- 9.12.1 Overview
- 9.12.2 Financials
- 9.12.3 Product Portfolio
- 9.12.4 Business Strategy
- 9.12.5 Recent Developments
- 9.13 World Courier
- 9.13.1 Overview
- 9.13.2 Financials
- 9.13.3 Product Portfolio
- 9.13.4 Business Strategy
- 9.13.5 Recent Developments
- 9.14 Biotronik
- 9.14.1 Overview
- 9.14.2 Financials
- 9.14.3 Product Portfolio
- 9.14.4 Business Strategy
- 9.14.5 Recent Developments
- 9.15 Deutsche Post DHL
- 9.15.1 Overview
- 9.15.2 Financials
- 9.15.3 Product Portfolio
- 9.15.4 Business Strategy
- 9.15.5 Recent Developments
- 9.16 DB Schenker
- 9.16.1 Overview
- 9.16.2 Financials
- 9.16.3 Product Portfolio
- 9.16.4 Business Strategy
- 9.16.5 Recent Developments
- 9.17 CEVA Logistics
- 9.17.1 Overview
- 9.17.2 Financials
- 9.17.3 Product Portfolio
- 9.17.4 Business Strategy
- 9.17.5 Recent Developments
- 9.18 Agility
- 9.18.1 Overview
- 9.18.2 Financials
- 9.18.3 Product Portfolio
- 9.18.4 Business Strategy
- 9.18.5 Recent Developments
- 9.19 SF Express
- 9.19.1 Overview
- 9.19.2 Financials
- 9.19.3 Product Portfolio
- 9.19.4 Business Strategy
- 9.19.5 Recent Developments
- 9.20 Biosensors International
- 9.20.1 Overview
- 9.20.2 Financials
- 9.20.3 Product Portfolio
- 9.20.4 Business Strategy
- 9.20.5 Recent Developments
- 9.21 Others.
- 9.21.1 Overview
- 9.21.2 Financials
- 9.21.3 Product Portfolio
- 9.21.4 Business Strategy
- 9.21.5 Recent Developments
- 9.1 FedEx
List Of Figures
Figures No 1 to 26
List Of Tables
Tables No 1 to 77
Report Methodology
In order to get the most precise estimates and forecasts possible, Custom Market Insights applies a detailed and adaptive research methodology centered on reducing deviations. For segregating and assessing quantitative aspects of the market, the company uses a combination of top-down and bottom-up approaches. Furthermore, data triangulation, which examines the market from three different aspects, is a recurring theme in all of our research reports. The following are critical components of the methodology used in all of our studies:
Preliminary Data Mining
On a broad scale, raw market information is retrieved and compiled. Data is constantly screened to make sure that only substantiated and verified sources are taken into account. Furthermore, data is mined from a plethora of reports in our archive and also a number of reputed & reliable paid databases. To gain a detailed understanding of the business, it is necessary to know the entire product life cycle and to facilitate this, we gather data from different suppliers, distributors, and buyers.
Surveys, technological conferences, and trade magazines are used to identify technical issues and trends. Technical data is also gathered from the standpoint of intellectual property, with a focus on freedom of movement and white space. The dynamics of the industry in terms of drivers, restraints, and valuation trends are also gathered. As a result, the content created contains a diverse range of original data, which is then cross-validated and verified with published sources.
Statistical Model
Simulation models are used to generate our business estimates and forecasts. For each study, a one-of-a-kind model is created. Data gathered for market dynamics, the digital landscape, development services, and valuation patterns are fed into the prototype and analyzed concurrently. These factors are compared, and their effect over the projected timeline is quantified using correlation, regression, and statistical modeling. Market forecasting is accomplished through the use of a combination of economic techniques, technical analysis, industry experience, and domain knowledge.
Short-term forecasting is typically done with econometric models, while long-term forecasting is done with technological market models. These are based on a synthesis of the technological environment, legal frameworks, economic outlook, and business regulations. Bottom-up market evaluation is favored, with crucial regional markets reviewed as distinct entities and data integration to acquire worldwide estimates. This is essential for gaining a thorough knowledge of the industry and ensuring that errors are kept to a minimum.
Some of the variables taken into account for forecasting are as follows:
• Industry drivers and constraints, as well as their current and projected impact
• The raw material case, as well as supply-versus-price trends
• Current volume and projected volume growth through 2032
We allocate weights to these variables and use weighted average analysis to determine the estimated market growth rate.
Primary Validation
This is the final step in our report’s estimating and forecasting process. Extensive primary interviews are carried out, both in-person and over the phone, to validate our findings and the assumptions that led to them.
Leading companies from across the supply chain, including suppliers, technology companies, subject matter experts, and buyers, use techniques like interviewing to ensure a comprehensive and non-biased overview of the business. These interviews are conducted all over the world, with the help of local staff and translators, to overcome language barriers.
Primary interviews not only aid with data validation, but also offer additional important insight into the industry, existing business scenario, and future projections, thereby improving the quality of our reports.
All of our estimates and forecasts are validated through extensive research work with key industry participants (KIPs), which typically include:
• Market leaders
• Suppliers of raw materials
• Suppliers of raw materials
• Buyers.
The following are the primary research objectives:
• To ensure the accuracy and acceptability of our data.
• Gaining an understanding of the current market and future projections.
Data Collection Matrix
| Perspective | Primary research | Secondary research |
| Supply-side |
|
|
| Demand-side |
|
|
Market Analysis Matrix
| Qualitative analysis | Quantitative analysis |
|
|
Prominent Player
- FedEx
- United Parcel Service of America Inc.
- Abiomed
- BioVentrix
- R. Bard
- LifeConEx
- Abbott Vascular
- Abiomed
- AtriCure
- UPS
- Air Canada
- VersaCold Logistics Services
- World Courier
- Biotronik
- Deutsche Post DHL
- DB Schenker
- CEVA Logistics
- Agility
- SF Express
- Biosensors International
- Others
FAQs
The restraints of the Pharmaceutical Logistics market is high operational cost of cold chain logistics.
The major driver for the Pharmaceutical Logistics market is increasing demand for cold chain logistics and rising need for pharmaceutical products due to increase in medication.
The “Storage” category dominated the market in 2022.
The key players in the market are FedEx, United Parcel Service of America Inc., Abiomed, BioVentrix, C. R. Bard, LifeConEx, Abbott Vascular, Abiomed, AtriCure, UPS, Air Canada, VersaCold Logistics Services, World Courier, Biotronik, Deutsche Post DHL, DB Schenker, CEVA Logistics, Agility, SF Express, Biosensors International, Others.
“Europe” had the largest share in the Pharmaceutical Logistics Market.
The global market is projected to grow at a CAGR of 5.5% during the forecast period, 2023-2032.
The Pharmaceutical Logistics Market size was valued at USD 68.5 Billion in 2023.